Latest News

Add to Favorites Subscribe Share
newswise-fb-share-

Showing results

110 of 282
Newswise: International Collaboration for Scientific Training Launched Between The Wistar Institute and Leiden University Medical Center in the Netherlands

International Collaboration for Scientific Training Launched Between The Wistar Institute and Leiden University Medical Center in the Netherlands

Wistar Institute

Wistar and Leiden University Medical Center (LUMC) formalized a memorandum of understanding between the two institutions to explore a postdoctoral training exchange program in immunology, cancer research and vaccine biology. The Wistar-Schoemaker International Postdoctoral Fellowship would bring recent Ph.D. graduates trained at LUMC to Wistar to advance their research education under the mentorship of cutting-edge biomedical research leaders.

Channels: All Journal News, Cancer, Education, Healthcare, Immunology, Technology, Vaccines,

Released:
15-Nov-2019 1:40 PM EST
Open in New Tab
Comment

Synthetic DNA Technology Applied as a Novel Strategy for Delivery of Anti-HIV Antibodies

Wistar Institute

Wistar scientists applied synthetic DNA-based technology to drive in vivo production of broadly neutralizing anti-HIV antibodies in small and large-animal models, providing proof of concept for a simple and effective next generation approach to HIV prevention and therapy. These results were published online in the Journal of Clinical Investigation.

Channels: AIDS and HIV, All Journal News, Healthcare, Technology,

Released:
8-Nov-2019 12:50 PM EST
Open in New Tab
Comment
Announcement
Newswise: Wistar Institute Researcher Awarded American Cancer Society Research Professorship

Wistar Institute Researcher Awarded American Cancer Society Research Professorship

Wistar Institute

The American Cancer Society has awarded a Research Professorship to Wistar's Dmitry l. Gabrilovich, M.D., Ph.D. This lifelong designation, accompanied by a five-year $400,000 commitment, is the most prestigious research grant made by ACS.

Channels: Cancer,

Released:
22-Oct-2019 10:30 AM EDT
Open in New Tab
Comment
Research Results
Newswise: $12.5 Million Grant Awarded to Wistar Extends Federal Support of the Institute’s Quest for Improved Targeted Therapies for Melanoma

$12.5 Million Grant Awarded to Wistar Extends Federal Support of the Institute’s Quest for Improved Targeted Therapies for Melanoma

Wistar Institute

Wistar and collaborating institutions have received a major grant from the National Institutes of Health to further research on new melanoma targeted therapies integrating the role of the tumor microenvironment in influencing response to therapy and development of resistance.

Channels: Cancer, National Institutes of Health (NIH),

Released:
17-Oct-2019 9:40 AM EDT
Open in New Tab
Comment
Announcement
Newswise: New Mechanism Fueling Brain Metastasis Discovered at Wistar

New Mechanism Fueling Brain Metastasis Discovered at Wistar

Wistar Institute

Wistar scientists described a novel mechanism through which astrocytes, the most abundant supporting cells in the brain, also promote cancer cell growth and metastasis in the brain.

Channels: Cancer, All Journal News,

Released:
9-Oct-2019 11:05 AM EDT
Open in New Tab
Comment
Announcement
Newswise: Targeting a Novel Regulator of Mitochondrial Cell Death Delivers Anticancer Activity in Preclinical Studies
  • Embargo expired:
    3-Oct-2019 10:00 AM EDT

Targeting a Novel Regulator of Mitochondrial Cell Death Delivers Anticancer Activity in Preclinical Studies

Wistar Institute

A novel anticancer molecule created by researchers at The Wistar Institute showed therapeutic activity in preclinical models of various cancer types.

Channels: All Journal News, Cancer, Cell Biology,

Released:
2-Oct-2019 3:05 PM EDT
Open in New Tab
Comment
Research Results
Newswise: NIH New Innovator Award Given to Wistar Researcher to Unravel the Metabolic Link Between Diet, Alcohol Consumption and Cancer
  • Embargo expired:
    1-Oct-2019 10:00 AM EDT

NIH New Innovator Award Given to Wistar Researcher to Unravel the Metabolic Link Between Diet, Alcohol Consumption and Cancer

Wistar Institute

The National Institutes of Health (NIH) today announced that Zachary T. Schug, Ph.D., assistant professor in the Molecular & Cellular Oncogenesis Program at Wistar, was awarded the prestigious NIH Director’s New Innovator Award in support of his research on the link between a high sugar/fat diet, alcohol use and cancer.

Channels: Addiction, Alcohol and Alcoholism, Cancer, Food Science, Nutrition, National Institutes of Health (NIH),

Released:
1-Oct-2019 9:40 AM EDT
Open in New Tab
Comment
Research Results
Newswise: Wistar Receives More than $12 Million to Fund 
Innovative Clinical Research on the Impact of Opioid Use on Response to Therapy in People Living with HIV

Wistar Receives More than $12 Million to Fund Innovative Clinical Research on the Impact of Opioid Use on Response to Therapy in People Living with HIV

Wistar Institute

Wistar was awarded two major grants totaling more than $12 million from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, to fund an international multidisciplinary clinical research consortium spearheaded by Wistar’s HIV Research Program.

Channels: Addiction, AIDS and HIV, Drugs and Drug Abuse, Immunology, Infectious Diseases, Public Health, Vaccines,

Released:
24-Sep-2019 10:05 AM EDT
Open in New Tab
Comment
Announcement
Newswise: Identification of a Novel Regulator of Mitochondrial Cell Death Reveals a Promising Target for Cancer Therapy

Identification of a Novel Regulator of Mitochondrial Cell Death Reveals a Promising Target for Cancer Therapy

Wistar Institute

Wistar researchers have described the role of mitochondrial fission factor (MFF) in controlling survival of cancer cells, suggesting the protein could represent a promising therapeutic target.

Channels: All Journal News, Cancer, Cell Biology,

Released:
19-Sep-2019 9:00 AM EDT
Open in New Tab
Comment
Announcement
Newswise: Major Grant Awarded to Wistar Supports Development of a Novel Therapeutic Approach for Antibiotic-resistant Bacteria

Major Grant Awarded to Wistar Supports Development of a Novel Therapeutic Approach for Antibiotic-resistant Bacteria

Wistar Institute

Wistar has received a grant of approximately $4.6 million from the National Institutes of Health in support of innovative research to tackle antibiotic resistance.

Channels: Drug Resistance, Public Health, Grant Funded News,

Released:
12-Sep-2019 3:05 PM EDT
Open in New Tab
Comment
Research Results

Showing results

110 of 282

Chat now!
0.94265